oleanolic acid has been researched along with Shock, Septic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ahmed, H; Amin, U; Jia, Z; Li, Y; Pitts, DR; Sun, X; Zhu, H | 1 |
Fuchs, RJ; Navas-Acien, A; Noel, S; Zheng, L | 1 |
Cao, X; Fang, J; Ju, DW; Wang, HB; Zheng, QY | 1 |
3 other study(ies) available for oleanolic acid and Shock, Septic
Article | Year |
---|---|
Triterpenoid CDDO-IM protects against lipopolysaccharide-induced inflammatory response and cytotoxicity in macrophages: The involvement of the NF-κB signaling pathway.
Topics: Cytokines; Humans; Inflammation; Lipopolysaccharides; Macrophages; NF-kappa B; Oleanolic Acid; Shock, Septic; Signal Transduction; Triterpenes | 2022 |
The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Cells, Cultured; Female; Gene Expression Regulation; Humans; Interleukin-6; Leukocytes, Mononuclear; Male; Middle Aged; NF-E2-Related Factor 2; Oleanolic Acid; Reactive Oxygen Species; RNA, Messenger; Shock, Septic; Signal Transduction; Young Adult | 2014 |
Esculentoside A inhibits tumor necrosis factor, interleukin-1, and interleukin-6 production induced by lipopolysaccharide in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Interleukin-1; Interleukin-6; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred ICR; Oleanolic Acid; Regression Analysis; Saponins; Shock, Septic; Thymus Gland; Tumor Necrosis Factor-alpha | 1998 |